09:52 AM EST - Revive Therapeutics Ltd. : Announced its results for the three months ended September 30, 2016. Cash and cash equivalents at September 30, 2016 totaled $2,100,339 (June 30, 2016 - $1,333,239). The net loss was $357,704 (three months ended September 30, 2015 - $912,799). Revive Therapeutics Ltd.
shares V.RVV are trading unchanged at $0.12.
